NCT07257055 · Recruiting
Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

Start your clinical trial request

Sign in to choose who this request is for, add supporting documents, and send it to our clinical team.

Your request is reviewed and a WeTrials Clinical Navigator will contact you in 1–2 business days. Your profiles and documents stay private to you.

New to WeTrials? Continuing creates your account.